Clinical Trial Update: EGFR Mutation Targeting Molecular Probe for PET Imaging

View source ↗

Summary

A clinical trial is evaluating an EGFR mutation-targeting molecular probe for PET imaging, conducted by Peking University Cancer Hospital & Institute; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• EGFR mutation-targeting molecular probe for PET imaging

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Cancer | Status: NOT_YET_RECRUITING